Morales-Bayuelo Alejandro
Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT), Proyecto Postdoctoral No. 3150035, Talca, 3660300, Chile.
Molecules. 2017 Jun 21;22(6):1027. doi: 10.3390/molecules22061027.
remains one of the world's most devastating pathogens. For this reason, we developed a study involving 3D pharmacophore searching, selectivity analysis and database screening for a series of anti-tuberculosis compounds, associated with the protein kinases A, B, and G. This theoretical study is expected to shed some light onto some molecular aspects that could contribute to the knowledge of the molecular mechanics behind interactions of these compounds, with anti-tuberculosis activity. Using the Molecular Quantum Similarity field and reactivity descriptors supported in the Density Functional Theory, it was possible to measure the quantification of the steric and electrostatic effects through the Overlap and Coulomb quantitative convergence (alpha and beta) scales. In addition, an analysis of reactivity indices using global and local descriptors was developed, identifying the binding sites and selectivity on these anti-tuberculosis compounds in the active sites. Finally, the reported pharmacophores to PKn A, B and G, were used to carry out database screening, using a database with anti-tuberculosis drugs from the Kelly Chibale research group (http://www.kellychibaleresearch.uct.ac.za/), to find the compounds with affinity for the specific protein targets associated with PKn A, B and G. In this regard, this hybrid methodology (Molecular Mechanic/Quantum Chemistry) shows new insights into drug design that may be useful in the tuberculosis treatment today.
仍然是世界上最具毁灭性的病原体之一。因此,我们开展了一项研究,涉及对一系列与蛋白激酶A、B和G相关的抗结核化合物进行三维药效团搜索、选择性分析和数据库筛选。这项理论研究有望为一些分子层面的问题提供线索,这些问题可能有助于了解这些具有抗结核活性的化合物相互作用背后的分子机制。利用密度泛函理论支持的分子量子相似性场和反应性描述符,通过重叠和库仑定量收敛(α和β)尺度,可以测量空间和静电效应的量化。此外,还开展了使用全局和局部描述符的反应性指数分析,确定了这些抗结核化合物在活性位点的结合位点和选择性。最后,利用报道的针对蛋白激酶A、B和G的药效团,对凯利·奇巴莱研究小组的抗结核药物数据库(http://www.kellychibaleresearch.uct.ac.za/)进行数据库筛选,以找到对与蛋白激酶A、B和G相关的特定蛋白靶点具有亲和力的化合物。在这方面,这种混合方法(分子力学/量子化学)为药物设计提供了新的见解,可能对当今的结核病治疗有用。